Related Experiment Videos
CD 34 expression in chronic and neoplastic liver diseases
I Di Carlo1, F Fraggetta, R Lombardo
1Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, University of Catania, Catania, Italy. idicarlo@mbox.unict.it
Panminerva Medica
|November 16, 2002
Summary
CD34 expression is a valuable marker for diagnosing liver conditions. Increased CD34 staining in liver tissue helps differentiate hepatocellular carcinoma (HCC) from non-cancerous liver, aiding in diagnosis.
Area of Science:
- Hepatology
- Oncology
- Immunohistochemistry
Background:
- Hepatic sinusoidal capillarisation is common in chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC).
- CD34 is a marker used to study angiogenesis and vascular changes in liver disease.
Purpose of the Study:
- To investigate the expression and distribution of CD34 in chronic liver disease and HCC.
- To evaluate the diagnostic implications of CD34 as a marker in liver pathology.
Main Methods:
- Studied 65 liver tissue samples including normal liver, chronic inflammation, cirrhosis, hepatocellular adenoma, and HCC.
- Utilized immunohistochemistry with CD34 staining on formalin-fixed, paraffin-embedded tissue specimens.
Main Results:
- Normal liver sinusoids showed no CD34 immunoreactivity.
- CD34 staining was focal in chronic hepatitis, increased in cirrhotic nodules, and diffuse/strong in HCC and hepatocellular adenoma.
- CD34 highlights angiogenesis in HCC.
Conclusions:
- CD34 immunoreactivity effectively evaluates angiogenesis in HCC.
- CD34 aids in distinguishing well-differentiated HCC from non-neoplastic liver tissue.
- Further research is needed on CD34's role in HCC staging and prognosis.